Grande E - Search Results

1

Bruton's tyrosine kinase (BTK) as a promising target in solid tumors.

Molina-Cerrillo J, Alonso-Gordoa T, Gajate P, Grande E. Molina-Cerrillo J, et al. Among authors: grande e. Cancer Treat Rev. 2017 Jul;58:41-50. doi: 10.1016/j.ctrv.2017.06.001. Epub 2017 Jun 9. Cancer Treat Rev. 2017. PMID: 28641100 Review.

2

Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs).

Grande E, Díez JJ, Pachón V, Carrato A. Grande E, et al. Clin Transl Oncol. 2010 Jul;12(7):481-92. doi: 10.1007/s12094-010-0541-5. Clin Transl Oncol. 2010. PMID: 20615825 Review.

3

Targeting oncogenic ALK: a promising strategy for cancer treatment.

Grande E, Bolós MV, Arriola E. Grande E, et al. Mol Cancer Ther. 2011 Apr;10(4):569-79. doi: 10.1158/1535-7163.MCT-10-0615. Mol Cancer Ther. 2011. PMID: 21474455 Review.

4

Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?

Grande E, Capdevila J, Barriuso J, Antón-Aparicio L, Castellano D. Grande E, et al. Cancer Metastasis Rev. 2012 Jun;31(1-2):47-53. doi: 10.1007/s10555-011-9328-6. Cancer Metastasis Rev. 2012. PMID: 22105614 Review.

5

New targeted approaches against the ubiquitin-proteasome system in gastrointestinal malignancies.

Grande E, Earl J, Fuentes R, Carrato A. Grande E, et al. Expert Rev Anticancer Ther. 2012 Apr;12(4):457-67. doi: 10.1586/era.12.26. Expert Rev Anticancer Ther. 2012. PMID: 22500683 Review.

6

The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluation.

De Dosso S, Grande E, Barriuso J, Castellano D, Tabernero J, Capdevila J. De Dosso S, et al. Among authors: grande e. Cancer Metastasis Rev. 2013 Dec;32(3-4):465-77. doi: 10.1007/s10555-013-9421-0. Cancer Metastasis Rev. 2013. PMID: 23589060 Review.

7

What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?

Capdevila J, Carrato A, Tabernero J, Grande E. Capdevila J, et al. Among authors: grande e. Crit Rev Oncol Hematol. 2014 Nov;92(2):83-106. doi: 10.1016/j.critrevonc.2014.05.004. Epub 2014 May 14. Crit Rev Oncol Hematol. 2014. PMID: 24924525 Review.

8

Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumors.

Valle JW, Faivre S, Hubner RA, Grande E, Raymond E. Valle JW, et al. Among authors: grande e. Cancer Treat Rev. 2014 Dec;40(10):1230-8. doi: 10.1016/j.ctrv.2014.09.001. Epub 2014 Sep 16. Cancer Treat Rev. 2014. PMID: 25283354 Free article.

9

GEP-NETs update: Biotherapy for neuroendocrine tumours.

Alonso-Gordoa T, Capdevila J, Grande E. Alonso-Gordoa T, et al. Among authors: grande e. Eur J Endocrinol. 2015 Jan;172(1):R31-46. doi: 10.1530/EJE-14-0354. Eur J Endocrinol. 2015. PMID: 25430657 Review.

10

Advances in thyroid cancer treatment: latest evidence and clinical potential.

Alonso-Gordoa T, Díez JJ, Durán M, Grande E. Alonso-Gordoa T, et al. Among authors: grande e. Ther Adv Med Oncol. 2015 Jan;7(1):22-38. doi: 10.1177/1758834014551936. Ther Adv Med Oncol. 2015. PMID: 25553081 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters